TuHURA Biosciences, Inc./NV Total Assets

Quick Answer

TuHURA Biosciences, Inc./NV reported Total Assets of $27.35 million for the year ending 2025.

  • TuHURA Biosciences, Inc./NV showed an increase of +37.0% in Total Assets from 2024 to 2025.
  • This data is from TuHURA Biosciences, Inc./NV's annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2011: $10.7 thousand | Q3 2011: $6.8 thousand | Q4 2011: $805.00 | Q2 2012: $1.8 thousand | Q1 2013: $7.69 million | Q2 2013: $6.52 million | Q3 2013: $5.39 million | Q4 2013: $4.32 million | Q1 2014: $3.75 million | Q3 2014: $4.50 million | Q4 2014: $4.13 million | Q2 2015: $2.58 million | Q4 2015: $2.18 million | Q1 2016: $1.16 million | Q3 2016: $5.05 million | Q4 2016: $3.59 million | Q1 2017: $2.34 million | Q3 2017: $14.45 million | Q4 2017: $12.22 million | Q1 2018: $9.68 million | Q3 2018: $4.75 million | Q4 2018: $4.04 million | Q1 2019: $2.46 million | Q3 2019: $8.36 million | Q4 2019: $6.51 million | Q1 2020: $5.10 million | Q3 2020: $23.13 million | Q4 2020: $20.49 million | Q1 2021: $18.85 million | Q3 2021: $22.34 million | Q4 2021: $17.72 million | Q1 2022: $12.80 million | Q3 2022: $13.21 million | Q4 2022: $9.92 million | Q1 2023: $6.74 million | Q3 2023: $1.48 million | Q1 2024: $7.45 million | Q2 2024: $6.20 million | Q3 2024: $4.14 million | Q1 2025: $14.64 million | Q2 2025: $34.62 million | Q3 2025: $25.70 million.
  • Over the full 16 years of available data (2012 to 2025), TuHURA Biosciences, Inc./NV's Total Assets has grown by 14,861.0%.
  • Historical annual values: Fiscal year 2025: $27.35 million | Fiscal year 2024: $19.97 million | Fiscal year 2024: $6.20 million | Fiscal year 2023: $4.36 million | Fiscal year 2023: $3.98 million | Fiscal year 2022: $15.95 million | Fiscal year 2021: $13.54 million | Fiscal year 2020: $2.94 million | Fiscal year 2019: $4.04 million | Fiscal year 2018: $7.07 million | Fiscal year 2017: $7.91 million | Fiscal year 2016: $6.36 million | Fiscal year 2015: $2.58 million | Fiscal year 2014: $5.00 million | Fiscal year 2013: $4.32 million | Fiscal year 2012: $182.8 thousand.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: